VENROCK ASSOCIATES IV L P

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 14% 8.2% 15.1%
Success rate 84% 68% 82%
Transactions
8 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -28%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
VENROCK ASSOCIATES IV L P's trades of Bellerophon Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2019-10-28 2019-10-28
S Sale
52,976 -18.0%
302.01
US$1,843,248 		52,976 -18.0% 302.01 US$1,843,248
2019-10-28 2019-10-28
S Sale
13,549 -32.0%
355.85
US$835,902 		13,549 -32.0% 355.85 US$835,902
2019-10-28 2019-10-25
S Sale
89,004 +23.1%
409.28
US$4,931,316 		89,004 +23.1% 409.28 US$4,931,316
2019-10-28 2019-10-25
S Sale
56,242 -0.8%
0.45
US$25,511 		56,242 -0.8% 0.45 US$25,511
2019-10-28 2019-10-24
S Sale
704,595 -9.4%
0.50
US$353,354 		704,595 -9.4% 0.50 US$353,354
2019-10-28 2019-10-24
S Sale
704,595 -9.4%
0.50
US$353,354 		704,595 -9.4% 0.50 US$353,354
2019-03-14 2019-01-23
B Purchase
142,857 +1.9%
0.70
US$100,000 		142,857 +1.9% 0.70 US$100,000
2019-03-14 2019-01-23
B Purchase
142,857 +1.9%
0.70
US$100,000 		142,857 +1.9% 0.70 US$100,000